AXN

Aoxing Pharmaceutical Company Inc.
AXN

Delisted

AXN was delisted on the 16th of October, 2017.

Back to rankings

8 hedge funds and large institutions have $53K invested in Aoxing Pharmaceutical Company Inc. in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$37.8K
2
+$16.7K
3
+$4.85K
4
LTFS
Ladenburg Thalmann Financial Services
Florida
+$1.06K

Top Sellers

1
-$36K
2
-$4.04K
3
-$2K
4
Creative Planning
Creative Planning
Kansas
-$2K
5
UBS Group
UBS Group
Switzerland
-$142
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$22K
Citadel Advisors
2
Citadel Advisors
Florida
$10K
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$7K
UBS Group
4
UBS Group
Switzerland
$4K
Barclays
5
Barclays
United Kingdom
$4K
TSS
6
Two Sigma Securities
New York
$3K
EWM
7
Evercore Wealth Management
New York
$2K
LTFS
8
Ladenburg Thalmann Financial Services
Florida
$1K
Renaissance Technologies
9
Renaissance Technologies
New York
–
FWM
10
Focused Wealth Management
New York
–
Creative Planning
11
Creative Planning
Kansas
–